Document is current
Any future updates will be listed below
-
Authors
Hong, Soojung
Daniels, Benjamin
van Leeuwen, Marina T.
Pearson, Sallie-Anne
Vajdic, Claire M.
-
Funding
Funding for this research was provided by:
University of New South Wales (1012141)
a Cooperative Research Centre Project (CRC-P) Grant from the Australian Government Department of Industry, Innovation and Science (CRC-P-439)
- License Information
-
More Information
Article History
Received: 22 October 2021
Accepted: 11 January 2022
First Online: 20 January 2022
Declarations
:
: This study was approved by the New South Wales Population and Health Services Research Ethics Committee (Reference 2013/11/494). The requirement for informed consent was waived because the investigators did not receive personally identifying information. Data access was granted by the Services Australia External Request Evaluation Committee (Approval Number: RMS0825).
: Not applicable.
: Sallie-Anne Pearson is a member of the Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory Committee. The views expressed in this paper do not represent those of either Committee. The Centre for Big Data Research in Health, UNSW Sydney has received funding from AbbVie Australia to conduct research unrelated to the present study. AbbVie did not have any knowledge of, or involvement in, the present study. The remaining authors declare no competing interests.
